Furthermore, recent evidence reveals that βIII-tubulin overexpression may be more common in certain breast cancer subtypes, including HER2-positive and basal-like/triple-negative, and may contribute to their aggressiveness [39]. This evidence concerns the gene ERBB2 and breast cancer.